Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination
Clinical trial NCT02485912 · COMPLETED
Trial details
- NCT number
- NCT02485912
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.